AIM ImmunoTech Inc. (NYSE:AIM)’s share price gapped down before the market opened on Wednesday . The stock had previously closed at $2.09, but opened at $1.47. AIM ImmunoTech shares last traded at $0.83, with a volume of 3,376,061 shares traded.
The company has a quick ratio of 2.15, a current ratio of 2.15 and a debt-to-equity ratio of 0.87.
AIM ImmunoTech (NYSE:AIM) last posted its quarterly earnings data on Thursday, August 15th. The company reported ($1.07) earnings per share for the quarter. AIM ImmunoTech had a negative return on equity of 219.87% and a negative net margin of 2,673.84%. The company had revenue of $0.03 million for the quarter.
AIM ImmunoTech Inc, an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency disorders in the United States. The company's products include Alferon N Injection, an injectable formulation of natural alpha interferon to treat a category of genital warts, a sexually transmitted disease; and Ampligen for the treatment of chronic fatigue syndrome (CFS).
Featured Story: Convertible Shares
Receive News & Ratings for AIM ImmunoTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AIM ImmunoTech and related companies with MarketBeat.com's FREE daily email newsletter.